Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triazolam dosing for middle-of-the-night insomnia
2013-000078-30Phase 4Completed
- Sponsor
- Valeas
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of triazolam in Insomnia, sponsored by Valeas. Primary endpoint: Efficacy of different triazolam dosage. Started Feb 2013; status: completed.
02
Drugs
triazolam
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2013-000078-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000078-30.